Schedule 14A 04.19.2012


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A
 
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No.     )
 
Filed by the Registrant x Filed by a Party other than the Registrant ¨
 
Check the appropriate box:
 
¨ 
Preliminary Proxy Statement
 
¨ 
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
 
¨ 
Definitive Proxy Statement
 
x 
Definitive Additional Materials
 
¨ 
Soliciting Material Pursuant to §240.14a-12
 
 
BIO-RAD LABORATORIES, INC.

(Name of Registrant as Specified In Its Charter)
 
 
  

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
 
x 
No fee required.
 
¨ 
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
 
 
(1) 
Title of each class of securities to which transaction applies:
 
  
 
 
(2) 
Aggregate number of securities to which transaction applies:
 
  
 




 
(3) 
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
  
 
 
(4) 
Proposed maximum aggregate value of transaction:
 
  
 
 
(5) 
Total fee paid:
 
  
 
 
 
¨ 
Fee paid previously with preliminary materials.
 
¨ 
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 
 

 
(1) 
Amount Previously Paid:
 
  
 
 
(2) 
Form, Schedule or Registration Statement No.:
 
  
 
 
(3) 
Filing Party:
 
  
 
 
(4) 
Date Filed:
 
  
 
 
Notes:





BIO-RAD LABORATORIES, INC.
1000 Alfred Nobel Drive
Hercules, California 94547
 
 
ADDITIONAL MATERIAL FOR PROXY STATEMENT
FOR THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON APRIL 24, 2012
 
 
TO THE STOCKHOLDERS OF BIO-RAD LABORATORIES, INC.:
The Board of Directors of Bio-Rad Laboratories, Inc. (the “Company”) regrets to report that David Schwartz passed away on April 1, 2012 at the age of 88. Mr. Schwartz was the Chairman of the Board of Directors and co-founder of the Company.
Mr. Schwartz was a nominee for election by holders of the Company's Class B Common Stock to the Board of Directors at the Company's annual meeting of stockholders to be held on April 24, 2012 (the “2012 Annual Meeting”). Because of Mr. Schwartz's death, Mr. Schwartz is removed as a nominee for election to the Board of Directors at the 2012 Annual Meeting. The Board of Directors has not designated a substitute nominee for Mr. Schwartz. Therefore, the Board of Directors will present only six nominees for election to the Company's Board of Directors at the 2012 Annual Meeting. The Board of Directors recommends that you vote FOR each of these six nominees in accordance with the class or classes of Common Stock that you hold.
If you have already voted your shares by proxy, your shares will be voted as specified in your prior vote with regards to the existing nominees, unless you choose to revoke your proxy. If you have not already voted your shares by proxy, you may still use the original proxy card that we previously distributed, and your vote with respect to nominees for director will be counted accordingly, other than votes with respect to Mr. Schwartz, which will be disregarded for purpose of the election of directors at the 2012 Annual Meeting.

By order of the Board of Directors
BIO-RAD LABORATORIES, INC.

/s/ Sanford S. Wadler

SANFORD S. WADLER, Secretary

April 19, 2012
Hercules, California